Savvy Update, 1/24/22: Updates from Kevin Sayer/Dexcom and John Sheridan/Tandem, Vitamin D Preserves Beta Function, DIY APS Offers Best Results, T1D Many Types?, Lyumjev Update, Mark Cuban’s CostPlus Drug Service
Dexcom CEO on G7’s global launch, COVID-19 slowing new patient adds, international growth was reported by Ricky Zipp for MedTechDive.com, 18 January 2022. After proving fairly resilient throughout the last two years, even as other medtechs were...
Savvy Updates, 1/17/22: Dexcom G7 Update with Kevin Sayer, “Medical” Wearables, NAFLD & T1D, Pancreatic Exocrine Insufficiency, Stair Walking & Insulin Sensitivity
Fitbit and Apple know their smartwatches aren’t medical devices. But do you? was written by Lisa Eadicicco for cnet.com, 14 January 2022. The line is blurring as wearables become more advanced. And it’s only getting more complicated. The Fitbit Sense...
Savvy Update 1/10/22: Dexcom G7?, Abbott Announces Lingo Sensor, Covid & T1D with Dr. Stephen Ponder, All About Vitamin D
What’s Going on with the Dexcom G7? was reported by Ross Wollen for DiabetesDaily.com, 3 January 2022. What’s going on with the Dexcom G7? Patients (and investors) want to know! Dexcom has been hyping the next generation of its groundbreaking continuous glucose...
Savvy Updates, 1/3/22: Beta Bionics Pivotal Trial, Log4j Cybersecurity, Exercise at High Altitudes, Cannabis and DKA, Amazon Pharmacy Shake-up, Endo Fellowships
Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial and Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial was released by Beta Bionics on GlobeNewswire.com, 22 December 2021. Beta Bionics,...
Savvy Update, 12/20/21: Stock Market on CGMs & Insulin Pumps, J&J Invokana Dangers, Medtronic FDA Warning Letter, Insulin Pumps and Body Fat, AI Algorithm/Alpha Fold
DIABETES BUSINESS NEWS: Diabetes tech market still has a clear favorite was published by Jason Aycock for SeekingAlpha.com, 15 December 2021. On the Continuous Glucose Monitoring, the market stayed strong this year, likely growing in the low-...
More Diabetes Blogs